Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference15 articles.
1. Zhang XL, Chen J, Zhang RJ, Wang WJ, Zhou Q, Qin XY. Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis. Int J Ophthalmol. 2013;6(4):546–52.
2. Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK, Diabetic Retinopathy Clinical Research Network. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118(4):609–14.
3. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115(9):1447–9. 1449.e1–10
4. Jager RD, Aiello LP, Patel SP, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina. 2004;24:676–98.
5. Vedantham V, Kolluru C, Ramasamy K. Persistent depot of triamcinolone acetonide after a single intravitreal injection. Indian J Ophthalmol. 2005;53:65–6.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. L’injection intravitreenne au CHU-IOTA a propos de 201 cas;Journal Français d'Ophtalmologie;2023-01
2. Triamcinolone;Reactions Weekly;2018-08